Enrollment Barriers for Molecular Targeted Trials.

Paydary, Koosha; DeLuca, Alli; Aggarwal, Rahul; Wall, Lauren; Stadler, Walter M

Paydary, Koosha; DeLuca, Alli; Aggarwal, Rahul; Wall, Lauren; Stadler, Walter M.

Afiliação

Paydary K; University of Chicago Medicine, Comprehensive Cancer Center, Chicago, Illinois.
DeLuca A; Tempus Labs, Chicago, Illinois.
Aggarwal R; University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco.
Wall L; University of Chicago Medicine, Comprehensive Cancer Center, Chicago, Illinois.
Stadler WM; University of Chicago Medicine, Comprehensive Cancer Center, Chicago, Illinois.

JAMA Oncol ; 9(6): 863-864, 2023 06 01.

Article em En | MEDLINE | ID: mdl-37022722

This quality improvement study examines the difficulties of patient accrual among patients with cancer and SETD2 variants.

Assuntos

Terapia de Alvo Molecular; Neoplasias; Humanos; Neoplasias/tratamento farmacológico; Seleção de Pacientes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia de Alvo Molecular / Neoplasias Limite: Humans Idioma: En Revista: JAMA Oncol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google